Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | THPO | P40225 | 2/20 | 1.00 |
| ▸ | MTOR | P42345 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 0.97 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.97 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.97 |
| ▸ | SCN1A | P35498 | 2/20 | 0.66 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.66 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.66 |
| ▸ | ABCB1 | P08183 | 4/20 | 0.60 |
| ▸ | ABCC1 | P33527 | 4/20 | 0.60 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.60 |
| ▸ | SLC29A1 | Q99808 | 4/20 | 0.60 |
| ▸ | CA12 | O43570 | 3/20 | 0.58 |
| ▸ | CA9 | Q16790 | 3/20 | 0.58 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2457928 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2D6THPOMTORMEN1 | |
| SCHEMBL2454357 | 1.00 | CYP3A4 (1.00) | CYP3A4CYP2D6THPOMTORMEN1 | |
| Hydrochloric Acid SCHEMBL5682553 | 0.99 | KMT2A (1.00) | CYP3A4CYP2D6THPOMTORMEN1 | |
| Hydrochloric Acid SCHEMBL29361001 | 0.99 | KMT2A (1.00) | CYP3A4CYP2D6THPOMTORMEN1 | |
| Butanedione SCHEMBL8444179 | 0.96 | CYP3A4 (0.93) | CYP3A4CYP2D6THPOMTORMEN1 | |
| SCHEMBL29759108 | 0.89 | CYP2D6 (0.80) | CYP3A4CYP2D6THPOMTORMEN1 | |
| Hydrochloric Acid SCHEMBL7883012 | 0.85 | MEN1 (0.77) | CYP3A4CYP2D6THPOMTORMEN1 | |
| SCHEMBL9681943 | 0.85 | CYP3A4 (0.73) | CYP3A4CYP2D6THPOMTORMEN1 | |
| SCHEMBL9680878 | 0.85 | CYP3A4 (0.73) | CYP3A4CYP2D6THPOMTORMEN1 | |
| SCHEMBL9680837 | 0.85 | CYP3A4 (0.73) | CYP3A4CYP2D6THPOMTORMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4540449-A1 | METHOD AND DEVICE FOR PRODUCING A NONWOVEN FABRIC | Reifenhäuser GmbH & Co. KG Maschinenfabrik (DE) | 2025-04-23 | — | — | EP | claimed |
| EP-4536236-A2 | METHODS OF MODULATING ATXN2 EXPRESSION | University of Utah Research Foundation (US) | 2025-04-16 | — | — | EP | claimed |
| CN-119431582-A | Anti-TMEM 106B antibodies and methods of use thereof | 艾莱克特有限责任公司 | 2025-02-14 | — | — | CN | claimed |
| CN-119384529-A | Method and apparatus for producing a nonwoven | 莱芬豪舍有限责任两合公司机器制造厂 | 2025-01-28 | — | — | CN | claimed |
| CN-118621059-A | Method for identifying authenticity of tomato variety and special SSR primer combination thereof | 北京市农林科学院 | 2024-09-10 | — | — | CN | claimed |
| US-20240166738-A1 | ANTI-TMEM106B ANTIBODIES FOR TREATING AND PREVENTING CORONAVIRUS INFECTIONS | HERCULES CAPITAL, INC., AS AGENT | 2024-05-23 | — | — | US | claimed |
| EP-4314063-A1 | ANTI-TMEM106B ANTIBODIES FOR TREATING AND PREVENTING CORONAVIRUS INFECTIONS | Alector LLC (US) | 2024-02-07 | — | — | EP | claimed |
| WO-2023242406-A1 | METHOD AND DEVICE FOR PRODUCING A NONWOVEN FABRIC | Reifenhäuser GmbH & Co. KG Maschinenfabrik (DE) | 2023-12-21 | — | — | WO | claimed |
| WO-2023239747-A2 | METHODS OF MODULATING ATXN2 EXPRESSION | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2023-12-14 | — | — | WO | claimed |
| CN-117157321-A | anti-TMEM 106B antibodies for the treatment and prevention of coronavirus infection | 艾莱克特有限责任公司 | 2023-12-01 | — | — | CN | claimed |
| US-8889615-B2 | Methods for promoting epithelialization and healing of chronic wounds | NEW YORK UNIVERSITY (US) | 2014-11-18 | — | — | US | claimed |
| US-20120289463-A1 | Compositions and Methods for Promoting Epithelialization and Wound Closure | NEW YORK UNIVERSITY (US) | 2012-11-15 | — | — | US | claimed |
| WO-2011082231-A1 | COMPOSITIONS AND METHODS FOR PROMOTING EPITHELIALIZATION AND WOUND CLOSURE | NEW YORK UNIVERSITY (US) | 2011-07-07 | — | — | WO | claimed |
| US-20050080260-A1 | Preparation of prodrugs for selective drug delivery | LUMINIDE | 2005-04-14 | — | — | US | claimed |
| EP-1469816-A2 | REDUCTION OF HAIR GROWTH | THE GILLETTE COMPANY (US) | 2004-10-27 | — | — | EP | claimed |
| US-20040198821-A1 | Reduction of hair growth | GILLETTE COMPANY, THE | 2004-10-07 | — | — | US | claimed |
| US-20040131568-A1 | Topical applying a fatty acid metabolism inhibitor; adriamycin, mercaptopropionic acid | GILLETTE COMPANY, THE | 2004-07-08 | — | — | US | claimed |
| US-20030202950-A1 | Reduction of hair growth | THE GILLETTE COMPANY | 2003-10-30 | — | — | US | claimed |
| US-20030153619-A1 | Applying on the skin, inhibiting fatty acid metabolism, using adriamycin, or enzyme inhibitors, dermatology | GILLETTE COMPANY, THE | 2003-08-14 | — | — | US | claimed |
| WO-2003063810-A2 | REDUCTION OF HAIR GROWTH | THE GILLETTE COMPANY (US) | 2003-08-07 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080260-A1 | Preparation of prodrugs for selective drug delivery | APEH, PAH, ALAD | CYP3A4 84/4885CYP2D6 18/4885THPO 341/4885 |
| US-20120289463-A1 | Compositions and Methods for Promoting Epithelialization and Wound Closure | GSK3B, GSK3A, GSKIP | CYP3A4 4840/4885CYP2D6 4881/4885THPO 3946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.